GlassScriptPhysician profile
Dharti Patel
NPI 1467756825
$4,255.19
in general payments reported to CMS, 2019-2025
8 companies · $288 in 2025
The $288 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $3,361 · 2024: $606 · 2025: $288.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,942 · Food and Beverage: $1,078 · Education: $235.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,942.39 |
| Food and Beverage | $1,077.79 |
| Education | $235.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $3,636.95 | 2023-2025 | Stratafix, Surgicel Nu-Knit, Vistaseal |
| Ethicon US, LLC | $166.26 | 2023 | Stratafix, Dermabond Prineo |
| Polynovo North America LLC | $128.46 | 2024 | Novosorb Btm |
| Glaxosmithkline, LLC. | $94.63 | 2024 | Nucala |
| Acumed LLC | $92.84 | 2024 | Acumed |
| Solventum Corporation | $88.25 | 2024 | V.A.C. Granufoam, V.A.C.Instill, Prevena |
| Depuy Synthes Sales INC. | $25.88 | 2025 | Na |
| Abbott Laboratories | $21.92 | 2024 | Alinity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dharti Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.